In the evolving world of aesthetics, the pursuit of “natural volume” and “biological lifting” has standardized the use of advanced polylactic acid technologies. As a premier representative of this category, Lenisna is a high-performance hybrid restructurer that utilizes the synergy of high-density PDLLA (Poly-D,L-Lactic Acid) and Hyaluronic Acid (HA).

Lenisna provides a specialized protocol designed to tighten facial contours while repairing deep tissue loss by stimulating the body’s endogenous collagen production.

Structural Bio-Matrix: Functional Dermal Engineering

Based on technical data regarding Lenisna, its regenerative pathway within the dermal layers can be defined as follows:

• Hybrid Formulation: Each vial contains a potent concentration of 170 mg PDLLA and 30 mg Hyaluronic Acid.

• Dual-Phase Induction: Upon application, the HA component provides immediate hydration and subtle shaping; meanwhile, the primary PDLLA micro-particles initiate a neocollagenesis (new collagen synthesis) process that unfolds over several months.

• Architectural Molecular Structure: The macro-particles, sized between 40-80 microns, create a structural scaffold within the deep dermis and subcutaneous tissue, reinforcing the skin’s internal framework.

Targeted Applications: Ideal Treatment Zones

Lenisna is considered an “architectural” support product, making it the preferred choice for areas requiring deeper structural volume:

• V-Line and Jawline: Defining the jawline and lifting sagging tissues for a sharper contour.

• Temples and Mid-Face: Restoring volume to hollow temples and sunken cheeks with a natural appearance.

• Deep Folds: Biologically softening pronounced nasolabial folds (smile lines).

• Body Contouring: Providing collagen support for areas experiencing elasticity loss, such as the abdomen, inner arms, and above the knees.

Market Analysis: Polylactic Acid Brand Comparison

There are various technological approaches to polylactic acid treatments globally. The differences between the market’s leading players are summarized below:

Brand and Technology Matrix

Critical Note: For PLLA-based products (Sculptra and Lanluma), a consistent post-treatment massage is vital to ensure the even distribution of crystalline particles and prevent nodule formation. In contrast, Lenisna (PDLLA-based) utilizes spherical particle technology, which integrates seamlessly into the tissue without the need for a mandatory massage protocol.

Frequently Asked Questions

Do I need to massage the treated area after Lenisna?

No. Due to Lenisna’s specific molecular structure and its distribution mechanism within the tissue, it does not require the rigorous, multi-day massage protocols (such as Sculptra’s 5-5-5 rule) typically associated with older polylactic acids.

Why do Sculptra and Lanluma require post-treatment massage?

Both products are composed of PLLA (Poly-L-Lactic Acid). To prevent these crystalline particles from clumping and to ensure a smooth collagen network is built, a clinical protocol of massaging 5 times a day for 5 days is essential.

Which product is FDA-approved?

Sculptra is the only polylactic acid product with the longest clinical history and FDA approval. Lenisna and Lanluma are reliable alternatives with international certifications (such as CE) that meet global medical standards.

Which product is preferred for body skin laxity?

Sculptra and Lanluma are high-volume options that have been used for years, particularly for buttocks and body contouring. Lenisna is generally preferred for body areas when the primary goal is “skin tightening and biological lifting.”

When will the results peak and how long do they last?

Once the collagen synthesis process is established, the biological rejuvenation achieved through this process maintains its structural integrity for a period of up to 24 months, depending on the patient’s lifestyle and skin quality.